User planetair6

Member for: 2 days (since Jul 2)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/ms-l6.html
About: Durvalumab after Chemoradiotherapy with regard to PD-L1 Articulating Inoperable Point III NSCLC Results in Considerable Advancement regarding Local-Regional Handle as well as All round Success within the Real-World Establishing.

Activity by planetair6

Score: 100 points (ranked #2)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for planetair6

Please log in or register to post on this wall.
...